Valeant Pharmaceuticals International (VRX)

  • NYSE: VRX
  • Mkt.Cap.:4.55B
Focused: Healthcare > Biopharmaceuticals (^BPHRM)

Classification

Sector
Healthcare
Biopharmaceuticals
- Focused
- Sector Pure-Play

Sector companies

Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :

Ticker Name Mkt.Cap.
PFE Pfizer Inc. 132.77B
NVS Novartis AG (ADR) 121.47B
RHHBY Roche Holding Ltd. (ADR) 120.28B
MRK Merck & Co., Inc. 110.98B
GSK GlaxoSmithKline plc (ADR) 102.01B

Relationships

Sample 8 relationships grouped by relationhip type.

Ticker Name
Competitors
Defined by Others AGN Allergan, Inc.
Defined by Others BVF Biovail Corporation (USA)
Customers
Defined by the Company CAH Cardinal Health, Inc.
Defined by the Company MCK McKesson Corporation
Suppliers
Defined by the Company MRK Merck & Co., Inc.
Defined by the Company NVS Novartis AG (ADR)
Partners
Defined by the Company AGN Allergan, Inc.
Defined by the Company GSK GlaxoSmithKline plc (ADR)
- Defined by the Company
- Defined by Others

Products & Services

Sample products & services from Biopharmaceuticals (^BPHRM) :

  • 8-MOP (Methoxsalen)
  • Ancobon (Flucytosine)
  • Aton Pharma, Inc. - Aton 001 (Injectable Vitamin K)

Relative Performance (1Y)

Relative Chart
  • - Valeant Pharmaceuticals International (VRX)
  • - S&P 500 INDEX (SPX)
  • - Healthcare > Biopharmaceuticals (^BPHRM)

Subscribe to an RSS Feed Research Reports

more »